Potential adverse effects of conventional treatment include nephrocalcinosis, hypercalcemia, hypercalciuria, hyperparathyroidism, and gastrointestinal issues, as well as exacerbated hypophosphatemia through elevation of circulating FGF23 levels and parathyroid hormone [2, 3, 5, 10]. This evidence concerns the gene FGF23 and hypophosphatemia.